Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 18/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | PTGES | O14684 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL221600 | 0.84 | ALDH1A1 (0.41) | RENMEN1GAAKMT2A | |
| SCHEMBL218707 | 0.80 | REN (0.47) | REN | |
| SCHEMBL14777605 | 0.80 | REN (0.47) | REN | |
| SCHEMBL220393 | 0.76 | MEN1 (0.47) | RENMEN1KMT2APTGESALOX5 | |
| SCHEMBL253884 | 0.74 | FOS (0.49) | RENMEN1ESR1GAAKMT2A | |
| SCHEMBL31666050 | 0.67 | LDHA (0.55) | MEN1KMT2APPARG | |
| SCHEMBL2575301 | 0.67 | LDHA (0.55) | MEN1KMT2APPARG | |
| SCHEMBL2568835 | 0.67 | LDHA (0.55) | MEN1KMT2APPARG | |
| SCHEMBL3914703 | 0.67 | REN (0.52) | REN | |
| SCHEMBL3912919 | 0.67 | REN (0.52) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8088954-B2 | Preparation of a saturated aldehyde | DSM IP ASSETS B.V. (NL) | 2012-01-03 | — | — | US | claimed |
| US-20100197972-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP ASSETS B.V. (NL) | 2010-08-05 | — | — | US | claimed |
| EP-2173696-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP Assets B.V. (NL) | 2010-04-14 | — | — | EP | claimed |
| WO-2009007461-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP ASSETS B.V. (NL) | 2009-01-15 | — | — | WO | claimed |
| US-8088954-B2 | Preparation of a saturated aldehyde | DSM IP ASSETS B.V. (NL) | 2012-01-03 | — | — | US | disclosed |
| US-20110294171-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP ASSETS B.V. (NL) | 2011-12-01 | — | — | US | disclosed |
| US-20100197972-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP ASSETS B.V. (NL) | 2010-08-05 | — | — | US | disclosed |
| EP-2173696-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP Assets B.V. (NL) | 2010-04-14 | — | — | EP | disclosed |
| WO-2009007461-A1 | PREPARATION OF A SATURATED ALDEHYDE | DSM IP ASSETS B.V. (NL) | 2009-01-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197972-A1 | PREPARATION OF A SATURATED ALDEHYDE | H1-0, F9, HRH4 | REN 112/4885MEN1 2853/4885ESR1 1765/4885 |
| US-20110294171-A1 | PREPARATION OF A SATURATED ALDEHYDE | H1-0, F9, HRH4 | REN 112/4885MEN1 2853/4885ESR1 1765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.